Description: Discover VEKLURY® (remdesivir), an FDA-approved antiviral treatment for COVID-19. See Important Safety Information.
This information is intended for US healthcare professionals.
Data from ACTT-1, a randomized, double-blind, placebo-controlled, phase 3 clinical trial in hospitalized adult patients with confirmed SARS-CoV-2 infection and mild, moderate, or severe COVID-19 (VEKLURY, n=541; placebo, n=521).
Recovery was defined by patients who were no longer hospitalized or hospitalized but no longer requiring ongoing medical care for COVID-19 .